>
The Homeless Industrial Complex:
The Lucid Cosmos Will Have More Range Than Any Tesla
Trump Admin Ends Medicaid Funding For Sex-Change Procedures On Kids
Strong 3D printable elastic polymer resists damage
Vitalik Buterin Says Ethereum Is Betting Its Future On Quantum Security And AI
Everything You Wanted To Know About Building A Cheap AI Setup (That Still Works)...
If They Were Human, They'd Be Arrested. Experts Respond To Rogue AI Breaches
Sodium Ion Batteries Will be 80% Cheaper & Last LONGER!
German startup SAXON Q has introduced a diamond-based quantum computing system...
Elon Musk To Build The Largest Building In The World - 100 Million Square Feet
Bitcoin 'Red Team' Says AI Is Finding 100s Of Critical Exploits Across Core Projects
EG4 Power Pro VS Ruixu Lithi VS Yixiang Budget Battery! Best Selling Battery Showdown!
Insect wings can kill bacteria without any chemicals!
Tesla Never Made An Electric Jet Boat, So This YouTuber Built One Himself

The report analyses the science and ethics behind the Health Resources and Services Administration's (HRSA) proposed rule to redefine hematopoietic (blood-forming) stem cells (HSC) as an organ. These are the cells that originate in bone marrow but are also found in the bloodstream. Today, over 70% of HSC donations are extracted from the bloodstream through a safe, non-invasive technique known as apheresis, after which the cells quickly regenerate.
In 2011, a federal court ruled compensating donors of HSC by apheresis to be legal due to the procedure's comparability to plasma and whole blood donation. HRSA's rule change would supersede the court and violate congressional intent, thereby making compensation to all HSC donors illegal under the National Organ Transplant Act. HRSA has until December 18th to move forward on its rule.